Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic

Publisher： John Wiley & Sons Inc

E-ISSN： 1520-6033|33|6|1468-1475

ISSN： 8756-7938

Source： BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol.33, Iss.6, 2017-11, pp. : 1468-1475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identifying low‐level sequence variants via next generation sequencing to aid stable CHO cell line screening

By  

BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol. 31, Iss. 4, 2015-07 ,pp. : 1077-1085

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustaining an efficient and effective CHO cell line development platform by incorporation of 24‐deep well plate screening and multivariate analysis

By  

BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol. 34, Iss. 1, 2018-01 ,pp. : 175-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

CHO host cell proteins change over time

By  

BIOTECHNOLOGY & BIOENGINEERING, Vol. 112, Iss. 6, 2015-06 ,pp. : vi-vi

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: On the cusp of rational CHO cell engineering

By  

BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol. 10, Iss. 7, 2015-07 ,pp. : 929-930

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimization of bioprocess conditions improves production of a CHO cell‐derived, bioengineered heparin

By  

BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol. 10, Iss. 7, 2015-07 ,pp. : 1067-1081

John Wiley & Sons Inc

Access to resources Recommend Favorite